ICU Medical, Incorporated (NASDAQ:ICUI) Director George A. Lopez Sells 20,000 Shares

Share on StockTwits

ICU Medical, Incorporated (NASDAQ:ICUI) Director George A. Lopez sold 20,000 shares of the stock in a transaction dated Tuesday, December 3rd. The stock was sold at an average price of $184.29, for a total transaction of $3,685,800.00. Following the transaction, the director now directly owns 368,864 shares in the company, valued at approximately $67,977,946.56. The transaction was disclosed in a filing with the SEC, which is available through this link.

Shares of ICUI stock opened at $184.73 on Wednesday. The firm has a market capitalization of $3.88 billion, a PE ratio of 25.27 and a beta of 0.92. The firm has a fifty day simple moving average of $170.69 and a two-hundred day simple moving average of $196.98. ICU Medical, Incorporated has a 12 month low of $148.89 and a 12 month high of $259.72.

ICU Medical (NASDAQ:ICUI) last released its quarterly earnings data on Monday, November 11th. The medical instruments supplier reported $1.65 earnings per share for the quarter, beating analysts’ consensus estimates of $1.62 by $0.03. The firm had revenue of $307.47 million for the quarter, compared to analyst estimates of $297.83 million. ICU Medical had a net margin of 5.66% and a return on equity of 12.13%. The business’s quarterly revenue was down 6.0% compared to the same quarter last year. During the same period last year, the firm earned $1.85 earnings per share. Research analysts anticipate that ICU Medical, Incorporated will post 7.1 EPS for the current year.

A number of analysts recently commented on the company. TheStreet lowered ICU Medical from a “b-” rating to a “c+” rating in a research report on Monday, August 12th. Zacks Investment Research lowered ICU Medical from a “hold” rating to a “sell” rating in a report on Wednesday, August 14th. ValuEngine raised ICU Medical from a “hold” rating to a “buy” rating in a research note on Tuesday, November 19th. Raymond James raised their price objective on ICU Medical from $185.00 to $203.00 and gave the company a “positive” rating in a research note on Tuesday, November 12th. Finally, BidaskClub upgraded ICU Medical from a “hold” rating to a “buy” rating in a report on Thursday, November 21st. One research analyst has rated the stock with a sell rating and three have given a buy rating to the company. The stock has a consensus rating of “Buy” and a consensus target price of $242.00.

Several institutional investors and hedge funds have recently bought and sold shares of ICUI. Metropolitan Life Insurance Co NY lifted its position in ICU Medical by 2.4% in the 3rd quarter. Metropolitan Life Insurance Co NY now owns 5,654 shares of the medical instruments supplier’s stock valued at $902,000 after acquiring an additional 135 shares in the last quarter. Voloridge Investment Management LLC acquired a new position in ICU Medical during the 3rd quarter valued at about $2,260,000. Public Employees Retirement System of Ohio increased its holdings in ICU Medical by 14.9% during the 3rd quarter. Public Employees Retirement System of Ohio now owns 21,915 shares of the medical instruments supplier’s stock worth $3,498,000 after purchasing an additional 2,850 shares in the last quarter. Point72 Asset Management L.P. bought a new stake in ICU Medical during the 3rd quarter worth approximately $35,745,000. Finally, California State Teachers Retirement System increased its holdings in ICU Medical by 0.6% during the 3rd quarter. California State Teachers Retirement System now owns 30,726 shares of the medical instruments supplier’s stock worth $4,904,000 after purchasing an additional 170 shares in the last quarter. Institutional investors own 91.85% of the company’s stock.

ICU Medical Company Profile

ICU Medical, Inc develops, manufactures, and sells medical devices used in vascular therapy, critical care, and oncology applications worldwide. It offers infusion therapy products comprising a tube running from a bottle or plastic bag containing a solution to a catheter inserted in a patient's vein.

Featured Article: How Do I Invest in Dividend Stocks

Insider Buying and Selling by Quarter for ICU Medical (NASDAQ:ICUI)

Receive News & Ratings for ICU Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ICU Medical and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


 
© 2006-2019 BBNS.